- Report
- May 2024
- 136 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
The Bowel Obstruction Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. Bowel Obstruction Drugs are used to treat conditions such as intestinal blockage, which can be caused by a variety of factors, including hernias, tumors, and adhesions. These drugs are typically administered orally or intravenously, and may include antispasmodics, laxatives, and antibiotics.
Bowel Obstruction Drugs are used to reduce pain and discomfort, as well as to reduce the risk of further complications. In some cases, surgery may be necessary to remove the obstruction.
Companies in the Bowel Obstruction Drug market include AstraZeneca, GlaxoSmithKline, Merck & Co., Pfizer, and Sanofi. Show Less Read more